R Squared Ltd Makes New Investment in TruBridge, Inc. (NASDAQ:TBRG)

R Squared Ltd purchased a new stake in shares of TruBridge, Inc. (NASDAQ:TBRG) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 7,800 shares of the company’s stock, valued at approximately $154,000. R Squared Ltd owned 0.05% of TruBridge as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. GAMMA Investing LLC bought a new position in TruBridge during the third quarter valued at about $26,000. Covestor Ltd bought a new position in shares of TruBridge during the 3rd quarter valued at about $28,000. First Horizon Advisors Inc. acquired a new position in shares of TruBridge in the 3rd quarter worth approximately $33,000. Point72 DIFC Ltd bought a new stake in shares of TruBridge in the 2nd quarter worth approximately $56,000. Finally, FMR LLC acquired a new stake in TruBridge during the third quarter valued at approximately $85,000. Institutional investors own 88.64% of the company’s stock.

TruBridge Price Performance

Shares of NASDAQ:TBRG opened at $24.25 on Thursday. The company has a market cap of $362.05 million, a P/E ratio of -5.93, a price-to-earnings-growth ratio of 4.41 and a beta of 0.67. The company’s fifty day moving average is $19.80 and its two-hundred day moving average is $15.02. The company has a quick ratio of 1.78, a current ratio of 1.80 and a debt-to-equity ratio of 1.00. TruBridge, Inc. has a 12-month low of $7.55 and a 12-month high of $24.50.

TruBridge (NASDAQ:TBRG) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.44 by ($0.73). TruBridge had a positive return on equity of 1.78% and a negative net margin of 17.72%. The business had revenue of $83.83 million during the quarter, compared to analysts’ expectations of $82.30 million. During the same period in the prior year, the company posted $0.39 earnings per share. Equities analysts expect that TruBridge, Inc. will post 0.07 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have issued reports on TBRG. Barclays lifted their price target on shares of TruBridge from $10.00 to $14.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $13.00 target price on shares of TruBridge in a research report on Friday, October 4th. Finally, Stephens increased their price target on TruBridge from $13.00 to $17.00 and gave the company an “equal weight” rating in a research report on Wednesday, November 20th.

Insider Buying and Selling

In other news, Director Mark V. Anquillare purchased 2,500 shares of the business’s stock in a transaction dated Monday, November 25th. The stock was bought at an average cost of $16.81 per share, with a total value of $42,025.00. Following the purchase, the director now directly owns 17,178 shares of the company’s stock, valued at approximately $288,762.18. This trade represents a 17.03 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 3.60% of the stock is currently owned by corporate insiders.

TruBridge Company Profile

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.